CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
about
Lack of Association of the Fat Mass and Obesity Associated (FTO) Gene rs9939609 Polymorphism with Breast Cancer Risk: a Systematic Review and Meta-Analysis Based on Case - Control StudiesAssociation of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-AnalysisAssociation between Polymorphisms of ERCC5 Gene and Susceptibility to Gastric Cancer: A Systematic Review and Meta-AnalysisA Survey on the Role of Interleukin-10 in Breast Cancer: A NarrativeCYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen
P2860
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
@en
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
@nl
type
label
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
@en
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
@nl
prefLabel
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
@en
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients.
@nl
P2093
P1476
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients
@en
P2093
Hossein Neamatzadeh
Mohammad Forat Yazdi
Mohsen Gholi-Nataj
Shiva Rafieian
Tahereh Nazari
P304
P577
2015-01-01T00:00:00Z